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Summary
 
We have established a method for real-time video analysis of the interaction of antigen-presenting
cells (APCs) with T cells. Green fluorescent protein expression controlled by a nuclear factor of
activated T cells (NFAT)-responsive promoter permits the visualization of productive antigen
presentation in single T cells. The readout is rapid (within 2 h) and semiquantitative and allows
analysis by video microscopy and flow cytometry. Using this approach, we demonstrate that
macrophages have the capacity to simultaneously activate multiple T cells. In addition, the in-
teraction of T cells with macrophages is extraordinarily dynamic: after initial stable contact, the
T cells migrate continuously on the surface of the macrophage and from APC to APC during
productive antigen presentation. Thus, T cells sum up signals from multiple interactions with
macrophages during stimulation.
Key words: nuclear factor of activated T cells • hybridoma • green ﬂuorescent protein •
video microscopy
 
M
 
acrophages comprise an important limb of the innate
immune system; the phagocytes recognize infectious
agents and kill them in phagocytic vacuoles (1). They
then activate the adaptive immune system by degrading the
organisms and presenting the pathogen-derived MHC class
II–bound peptides to T cells (2). Recent observations suggest
a central role for the actin cytoskeleton in mediating both
the physical interaction of the APC with the T cell, and the
subsequent signaling pathways leading to T cell activation
(3). An appreciation of the cross-talk between the TCR and
the cytoskeleton has given insight into how the TCR can
recognize an MHC–peptide complex when the affinity of
the TCR for the antigen is very low and the number of
ligands is limited (4–6).
Initial contact is established between adhesion molecules
 
like LFA-1 on the T cell and intracellular adhesion molecule 1
(ICAM-1) on the APC (7). These molecules then mediate
a large, low affinity adhesion zone between the cells. Con-
comitantly, CD2 on the T cell binds its cognate ligand on
the APC, leading to the establishment of a specialized mem-
brane zone that is enriched in TCRs and MHC–peptide
complexes (3, 8, 9). The high local densities of these mole-
cules allow TCRs to sample a vast number of MHC–pep-
tide complexes. Upon engagement of TCRs with cognate
antigen complexes and the initiation of active TCR signal-
ing, LFA-1 is converted from a low affinity state to a high
affinity state, thereby stabilizing the cell–cell interaction
(10). The stability of this interaction facilitates the stable es-
tablishment of a signaling zone that has been referred to
both as a supramolecular activation cluster (SMAC) and as
an “immunological synapse.” In this zone, T cell and APC
membranes are in tight (15 nm) apposition, and T cell mol-
ecules such as TCR/CD3, CD4, and CD28 are clustered.
In addition, this organized signaling zone recruits molecules
important for TCR signaling such as Lck, Fyn, Zap70, and
protein kinase C (PKC)-
 
u
 
 (3, 7, 11, 12). Recent evidence
suggests that cooperative signaling through the TCR and
costimulatory CD28 triggers an actomyosin-based translo-
cation of cholesterol-rich membrane lipid rafts, which carry
signaling molecules to the contact zone (9). TCR stimula-
tion also triggers changes in cell polarity and movement,
both of which appear to have a role in T cell activation
(13). Changes in T cell motility also have a role in T cell
activation; once the cells engage both ICAM-1 and the
MHC–peptide complex, they receive a stop signal that pre-
vents further movement and facilitates the establishment of
the organized signaling zone (14).
Although dendritic cells, macrophages, and B cells are all
capable of MHC class II–dependent antigen presentation,
most work on the morphological and cytoskeletal changes
associated with APC–T cell interactions has been carried
out using B cells. We have established a system that permits
examination in real time of APC–T cell interactions during
MHC class II antigen presentation. A T cell hybridoma,
DO11.10, was stably transfected with a construct in which
green fluorescent protein (GFP) expression is under the 
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control of a nuclear factor of activated T cells (NFAT)-reg-
ulated promoter (15, 16). Thus, upon productive interac-
tion with an APC, the T cell becomes fluorescent. Our
data demonstrate that macrophages can simultaneously acti-
vate a large number of T cells, and that the interaction of
the T cells with the macrophages is extraordinarily dynamic.
Although T cell–macrophage interactions need to be sus-
tained for 
 
z
 
2 h for productive activation, the T cells are
seen to move from one area of the macrophage to another,
as well as from one APC to the next. However, although
the T cells move around, they do stop long enough to per-
mit the recruitment of the requisite cytoskeletal elements and
signaling molecules to the site of cell–cell contact. These
data indicate that T cells can be stimulated by summing up
signals received during multiple sequential interactions with
an antigen-presenting macrophage.
 
Materials and Methods
 
Materials.
 
OVA peptide 323–339 was synthesized by Bio-
Synthesis. IFN-
 
g
 
 was obtained from Genzyme Corp. All other
reagents were obtained from Sigma Chemical Co. except where
indicated.
 
Cell Culture.
 
The I-A
 
d
 
–restricted OVA-specific murine T cell
hybridoma DO11.10, the I-A
 
b
 
–restricted E
 
a
 
-specific hybridoma
1H3.1, the H-2
 
b
 
 murine macrophage line BM12 (provided by Dr.
K. Rock, University of Massachusetts Medical School, Worcester,
MA), and the H-2
 
d
 
 murine macrophage line RAW 264.7 (no.
TIB-71; American Type Culture Collection) were grown in RPMI
containing 10% fetal bovine serum, 1% 
 
l
 
-glutamine, 100 U/ml
penicillin, and 100 
 
m
 
g/ml streptomycin. Cells were maintained at
37
 
8
 
C in a humidified incubator with a 5% CO
 
2
 
 atmosphere.
 
Plasmid Construction.
 
The vector pNFATeGFP contains the Neo
 
r
 
marker of pcDNA3 and drives enhanced GFP (eGFP) expression
under control of an NFAT-induced promoter. The CMV promoter
of pcDNA3 (Invitrogen) was replaced with the 0.2-kb ClaI-HindIII
fragment of NFATZH (17; provided by Steve Fiering, Fred Hutch-
inson Cancer Research Center, Seattle, WA) containing a promoter
consisting of three copies of the NFAT binding site linked to the
IL-2 promoter (
 
2
 
72 to 
 
1
 
47 of IL-2). The 0.7-kb NcoI-NotI frag-
ment of peGFP (Clontech) containing the coding region for eGFP
was then cloned downstream of the NFAT-induced promoter.
 
Transfection.
 
3 
 
3
 
 10
 
6
 
 DO11.10 cells were placed in 0.5 ml
sterile PBS in a 0.4-cm gap cuvette (Bio-Rad) together with 20 
 
m
 
g
DNA. The sample was electroporated with a Gene Pulser (Bio-
Rad) set at 250 
 
m
 
F and 300 V. The cells were grown for 24 h
before adding G418 (GIBCO BRL) to 1 mg/ml final concentra-
tion. After 10 d selection, the surviving cells were cloned by lim-
iting dilution. Clones were then screened for OVA-specific induc-
tion of GFP by APCs. One responding clone, 5.6, was designated
DO11-GFP and used for the experiments reported here.
 
Antigen Presentation Assay.
 
For presentation by RAW 264.7
cells, the cells were plated with 20 U/ml IFN-
 
g 
 
at 3 
 
3
 
 10
 
4
 
/well
in 96-well plates or 2 
 
3
 
 10
 
5
 
/well in 24-well plates and incubated
48 h before use. The cells were antigen loaded overnight with
OVA added from a 100 mg/ml sterile stock, or for 2 h with OVA
323–339 peptide. The cells were then rinsed once with medium,
DO11-GFP cells were added at 8 
 
3
 
 10
 
4
 
/well in 96-well plates or
2 
 
3
 
 10
 
5
 
 in 24-well plates, the plates were centrifuged at 450 
 
g
 
 to
initiate contact between the cells, and the cells were incubated
together at 37
 
8
 
C in a CO
 
2
 
 incubator for the indicated times.
Loose cells were transferred by vigorous pipetting into a fresh tube,
and adherent cells were released from the dish with PBS containing
1 mM EDTA and added to the loose cells. The cells were analyzed
by flow cytometry using a FACScan™ and CELLQuest™ software
(Becton Dickinson). To rapidly identify the different cell popula-
tions so as to gate on just the APCs or on the T cells, RAW 264.7
cells were prelabeled at the beginning of the experiment with
1,1
 
9
 
-dioctadecyl-3,3,3
 
9
 
,3
 
9
 
-tetramethylindocarbocyanine perchlo-
rate (DiI) or the DO11-GFP cells were prelabeled with Cell-
Tracker™ Orange (CTO; Molecular Probes) as follows. For DiI la-
beling, RAW 264.7 cells were collected by centrifugation, washed
one time with labeling buffer (300 mM glucose, 10 mM Hepes, pH
7.1), resuspended in labeling buffer containing 1 
 
m
 
g/ml DiI, and in-
cubated for 15 min at 37
 
8
 
C. The cells were then washed twice with
labeling buffer and once with medium before use. For CTO label-
ing, DO11 cells were collected by centrifugation and resuspended
in medium containing 500 nM CTO, incubated 15 min at 37
 
8
 
C,
washed twice with medium, and incubated for 30 min at 37
 
8
 
C be-
fore use. Separate experiments determined that neither of these
treatments had any measurable effect on the data presented.
 
Time-Lapse Video Microscopy.
 
RAW 264.7 cells were plated
48 h before use on 35-mm glass-bottomed microwell dishes
(MatTek Corp.) with 20 U/ml IFN-
 
g
 
, and OVA was added to
10 mg/ml for the final 16 h. DO11-GFP cells were added to the
dish at fivefold excess, centrifuged onto the RAW 264.7 cells to
initiate contact, and the dish was immediately mounted on a Axio-
phot microscope (Carl Zeiss, Inc.) equipped with a cooled CCD
camera (Princeton Instruments) and Metamorph™ digital imag-
ing software system for image collection (Universal Imaging).
Differential interference contrast (DIC) images were collected at
2-min intervals for the periods indicated in the text, and GFP im-
ages were collected before the first frame and after the last frame
of the series.
 
Results
 
Characterization of Antigen-specific Induction of GFP in DO11
Cells.
 
To visualize antigen-specific interactions of macro-
phages with T cells by continuous video microscopy, we
transfected T cells with a reporter construct that causes them
to express GFP upon productive engagement of an APC.
In this construct, GFP expression is regulated by a pro-
moter, comprising three copies of the NFAT binding site
linked to a minimal IL-2 promoter, that has been demon-
strated to faithfully report NFAT activity in T cells when
driving chloramphenicol acetyltransferase (CAT) or LacZ
expression (15–17). We transfected the OVA-specific T
cell hybridoma DO11.10 with this vector, selected stable
clones, and found that 
 
.
 
60% (12/19) of the clones showed
GFP expression upon NFAT activation. In this paper, we
report our results with a clone designated DO11-GFP. Iden-
tical results were obtained with additional clones.
The mouse macrophage cell line RAW 264.7 was stim-
ulated with IFN-
 
g
 
 to upregulate MHC class II expression
and incubated overnight with OVA. When DO11-GFP cells
were allowed to interact for 6 h with these macrophages,
cells in direct contact with the macrophages expressed GFP
(Fig. 1, A and B, arrows), whereas those physically sepa-
rated from the APC did not (Fig. 1, A and B, arrowhead).
By contrast, if the IFN-
 
g
 
–stimulated RAW 264.7 cells were 
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not first incubated with OVA, the DO11-GFP cells expressed
no GFP, even when contacting the APC (Fig. 1, C and D,
arrows). Examination of 
 
.
 
100 such pairs confirmed that
cell–cell contact was required for T cell stimulation as re-
ported by GFP expression; few GFP-positive DO11-GFP
cells were observed not in contact with a macrophage.
We next examined the antigen concentration depen-
dence of the response of DO11-GFP cells to RAW 264.7
cells. IFN-
 
g
 
–stimulated RAW 264.7 cells were loaded with
OVA 323–339 peptide at the indicated concentrations for
2 h before DO11-GFP cells were added. After 6 h of inter-
action, the cells were harvested and analyzed by flow cy-
tometry for GFP expression. As the peptide dose increased,
both the number of T cells expressing GFP and the relative
fluorescence intensity of the GFP-positive cells increased
(Fig. 2 A). At intermediate antigen concentrations, a bimo-
dal distribution of cells was observed, with some cells re-
sponding to stimulation while others did not respond. At
higher antigen concentrations, the cells became more uni-
formly GFP-positive. Translated into a dose–response curve
(Fig. 2 B), the data show that the stimulation is dose depen-
dent and saturable. Interestingly, the antigen dose that resulted
in the maximum number of cells becoming GFP-positive
was an order of magnitude lower than the dose required to
stimulate maximal GFP expression. This suggests that even
under conditions when all of the DO11-GFP cells were pro-
ductively interacting with antigen-presenting macrophages,
more antigen still resulted in a stronger NFAT-mediated
response in the hybridoma. This result was also obtained if
OVA was used as the antigen instead of synthetic peptide,
or if primary peritoneal macrophages were used as APCs
(data not shown). Similar data were obtained by transfect-
ing the NFAT-GFP reporter construct into the T cell hybrid-
oma 1H3.1 (18), which recognizes a peptide derived from
the I-E 
 
a
 
 chain, and then stimulating the cells with the I-A
 
b
 
macrophage cell line BM12 or by primary macrophages
(data not shown). Immunoblot analysis demonstrated that
GFP fluorescence accurately reflected the level of GFP ex-
pression in the T cell hybridoma (data not shown). These data
are at variance with previous observations using the same
promoter driving a 
 
b
 
-galactosidase reporter, which showed
that T cell activation occurs by a binary mechanism in which
the cells are either on or off (19, 20). A possible explanation
for this discrepancy might be the differences in stability of
GFP (long-lived) and 
 
b
 
-galactosidase (short-lived).
We next examined the temporal induction of GFP
Figure 1. Productive antigen-specific interaction induces GFP expres-
sion in a T cell hybridoma. IFN-g–stimulated RAW 264.7 cells were in-
cubated for 2 h with (A and B) or without (C and D) 100 mg/ml of the
OVA 323–339 peptide, and allowed to interact with a fivefold excess of
DO11-GFP cells for 6 h. In the presence of peptide, T cells in contact
with macrophages express GFP (B, arrows), whereas neighboring T cells
not in direct contact with macrophages do not (B, arrowhead). In the ab-
sence of peptide, the DO11-GFP cells are not stimulated to express GFP
(D, arrows) despite their adhesion to macrophages.
Figure 2. Analysis of antigen-induced GFP expression by flow cytometry. (A) RAW 264.7 cells were labeled with the fluorescent lipid DiI, stimulated
for 48 h with IFN-g, and loaded for 2 h with the indicated concentration of OVA 323–339 peptide. DO11-GFP cells were added at a 1:1 ratio, and the
cells were allowed to interact for 6 h. GFP expression in the DO11-GFP cells was analyzed by flow cytometry. (B) IFN-g–stimulated RAW 264.7 cells
were preloaded for 2 h with the indicated dose of antigenic peptide, mixed 1:1 with CTO-labeled DO11-GFP cells, and allowed to interact for 6 h. The
cells were harvested, and GFP expression in the T cell hybridoma was analyzed by flow cytometry. The percentage of T cells expressing GFP increased
as a function of peptide concentration (s), as did the average fluorescence of the GFP-positive cells (h). 
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expression during antigen presentation. IFN-
 
g
 
–stimulated
RAW 264.7 cells were loaded with the indicated dose of
OVA, and DO11-GFP cells were allowed to interact with
them for the indicated times. The T cells were subsequently
harvested, and the average fluorescence of the GFP-positive
cells was measured (Fig. 3). GFP expression was detectable
after 2 h and leveled off after 
 
z
 
12 h. The rate and extent of
GFP accumulation differed for different doses of OVA; higher
doses of antigen resulted in more rapid accumulation of
GFP to higher final levels in individual stimulated T cells.
 
Productive Macrophage–T Cell Interactions Are Dynamic.
 
The
rapid, antigen-specific expression of GFP in DO11-GFP
cells allowed real-time visualization of productive APC–T cell
interactions by video microscopy: we observed that macro-
phage–DO11-GFP cell interaction is dynamic. IFN-
 
g
 
–stim-
ulated RAW 264.7 cells were preloaded overnight with OVA,
DO11-GFP cells were added, and the cells were mounted
on a temperature-controlled microscope stage and observed
for 3 h. At the beginning of the experiment, no cells were
fluorescent, as shown in Fig. 4. After 3 h, many T cells in the
field were expressing GFP.
Fig. 4 illustrates several points about the dynamic interac-
tion between the RAW 264.7 and DO11-GFP cells. First, T
cells that were bound to macrophages for the entire 3 h (cells
B, C, and E) expressed more GFP than cells that bound to
macrophages later in the experiment (cells F, H, and I), con-
sistent with the dose and time dependence illustrated above.
Cells A, D, and G moved out of the field of vision during the
experiment and could not be followed. Generally, 1.5–2 h of
interaction was required for detection of GFP. In separate ex-
periments using populations of cells analyzed by flow cytom-
etry, we confirmed that separating macrophages from T cells
within 1.5 h of initiating the interaction prevented the induc-
tion of GFP in T cells (data not shown). Second, when rap-
idly moving T cells encountered antigen-presenting macro-
phages, the T cells became attached to the surface of the
macrophage, but not restricted to one region of the present-
ing cell. For example, cell F moved rapidly between 0.5 and
1.25 h across the field of view and attached to a macrophage.
It then wandered up and down one side of the macrophage,
being activated to the same extent as cells that interacted with
the macrophage for the same amount of time (cell H). Analy-
sis of a large number of T cells (
 
n
 
 5 
 
50) demonstrated that
90% of them moved around on the surface of macrophages
during antigen presentation. Third, macrophages are clearly
capable of interacting simultaneously with multiple T cells.
Cells B, C, D, and E all bound to the macrophage in the top
center of the field at some point in the series, whereas cells B,
C, F, and H all interacted with the macrophage in the center
of the field. In other experiments, as many as 10–12 T cells
could be observed interacting simultaneously with a single
macrophage (data not shown). Fourth, nearly 50% of T cells
(
 
n
 
 5 
 
50) that were bound to one macrophage migrated to
neighboring macrophages during the 3-h observation period.
Thus, cells B and C began the series on one macrophage and
ended on another. The fact that GFP expression was very
high in cells B and C after 3 h indicated that the interactions
with both macrophages were productive: cell C spent 0.5 h
on the first macrophage and 2.5 h on the second macrophage,
whereas cell B spent 1.25 h on the first macrophage and 1.75 h
on the second macrophage. Comparison of the high GFP
expression levels of cells B and C to the low expression level
of cell F (which only interacted with a macrophage for 1.75 h)
further supported the notion that the GFP expression levels in
cells B and C were the result of the cumulative interactions of
these cells with both macrophages. The data also indicate that
the time of interaction between the macrophage and T cell is
the predominant determinant of GFP expression, rather than
one macrophage being a better APC than another macro-
phage. Similarly dynamic interactions were observed between
the NFAT-GFP–transfected 1H3.1 hybridoma and macro-
phages (data not shown).
 
Discussion
 
We have used a novel system for examining the interac-
tion of macrophages with T cell hybridomas by video and
immunofluorescence microscopy and FACS
 
®
 
 analysis. Due
to the difficulty in transfecting primary T cells and T cell
lines, our studies were restricted to T cell hybridomas, which
may behave differently. Although the stimulation of the
NFAT pathway only reflects one aspect of T cell activation,
the rapidity of the response allows real-time analysis of pro-
ductive APC–T cell interactions. It has been known for a
long time that macrophages and dendritic cells can bind
many T cells at the same time; our system has permitted us
to directly observe these interactions and to conclude that a
single macrophage is capable of simultaneously activating
multiple T cells. Most interestingly, these interactions are
dynamic, and the T cells move both from contact site to con-
tact site on individual macrophages and from APC to APC
while being activated. We were surprised to observe that
the T cell–macrophage interactions were so dynamic, because
the observations of Dustin and colleagues demonstrated that
T cells stop migrating upon interaction with ICAM-1 and
Figure 3. Kinetics of antigen-dependent stimulation of GFP expression
in DO11-GFP cells. IFN-g–stimulated RAW 264.7 cells were loaded
overnight with OVA at a final concentration of 25 mg/ml (s), 2 mg/ml
(h), or 0.5 mg/ml (n). Control cells were also IFN-g stimulated but
were not incubated with antigen (j). CTO-labeled DO11-GFP cells
were added at a 1:1 ratio and allowed to interact with the RAW 264.7
cells for the indicated periods. The cells were harvested, and GFP expres-
sion in the T cell hybridoma was analyzed by flow cytometry. 
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MHC class II–peptide complex embedded in a lipid bilayer
(14, 21). It is possible that this inhibition of migration reflects
an initial event that permits the formation of a productive
contact zone, and that subsequent movement of T cells
could not be detected because the full repertoire of signals
required for T cell activation was not present. This view is
supported by the fact that the T cells do stop for some min-
utes at particular sites on the macrophage, perhaps allowing
the establishment of signaling junctions. Indeed, when in-
dividual macrophage–T cell pairs were observed by laser
scanning confocal microscopy, we noticed the recruitment
of cytoskeletal and signaling molecules such as actin, talin,
and tyrosine-phosphorylated proteins to the site of cell–cell
contact (data not shown), as has been described in other
studies of APC–T cell interactions (3, 22, 23). Interestingly,
T cells immobilized on a lipid bilayer containing ICAM-1
and the MHC class II–peptide complex can be stimulated to
move upon activation of PKC by phorbol esters (14). It is
well known that PKC is activated when T cells interact
productively with APCs, and PKC-
 
u
 
 translocates to the
sites of APC–T cell interaction (11). Thus, it is possible that
the stop signal is reversed by PKC upon T cell activation.
The data also imply that the contact zone need not be stable
for hours to mediate T cell activation, although T cells have
to interact continuously with macrophages for 
 
z
 
2 h to be ac-
tivated. This notion is further supported by the observation
that T cells that interacted continuously with antigen-pre-
senting macrophages for 3 h, albeit dynamically, were consid-
erably brighter than cells that interacted with the APCs for
shorter periods of time. In contrast to macrophages, previous
studies have demonstrated that B cells make stable 1:1 pairs
with T cells during antigen presentation (24, 25), and we also
observed that B cells invariably interact with DO11-GFP
cells in a one to one fashion (data not shown). These observa-
tions make teleological sense, since macrophages need to acti-
vate many T cells to establish a concerted Th1 response,
whereas a single B cell clone has more chance of being ex-
panded by the focused and sustained delivery of cytokines.
T cells need to interact with APCs for a sufficient length
of time to allow the TCR to sample the large array of MHC
class II–peptide complexes present on the surface of the
APC. This requires that the motile T cell rearranges its cyto-
skeleton and becomes static. Our data demonstrate that this
stasis is transient, and that the T cell–APC interaction is
quite dynamic during antigen presentation. Our data indi-
cate that T cells can be stimulated by summing up signals
received during multiple sequential interactions with an
antigen-presenting macrophage.
Figure 4. Time-lapse imag-
ing of macrophage–T cell inter-
actions. IFN-g–stimulated RAW
264.7 cells were loaded over-
night with 10 mg/ml OVA.
DO11-GFP cells were added at a
5:1 ratio to macrophages, the
cells were mounted on a temper-
ature-controlled microscope stage,
and cell–cell interactions were
continuously observed by video
microscopy for 3 h. The panels
show selected video images col-
lected at the indicated time in-
tervals after addition of DO11-
GFP cells. At the beginning of
the experiment (0 Hr.), no cells
expressed GFP (top left). After
3 h, many T cells in the field
were expressing GFP (bottom
right). Individual T cells are la-
beled alphabetically. 
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